Cubist Systematic Strategies’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $64.8K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.07M | Buy |
|
|||||
|
2023
Q4 | $268K | Buy |
|
|||||
|
2023
Q3 | $77.2K | Sell |
|
|||||
|
2023
Q2 | $613K | Sell |
|
|||||
|
2023
Q1 | $1.28M | Sell |
|
|||||
|
2022
Q4 | $2.5M | Buy |
|
|||||
|
2022
Q3 | $2.65M | Buy |
|
|||||
|
2022
Q2 | $552K | Sell |
|
|||||
|
2022
Q1 | $1.14M | Buy |
|
|||||
|
2021
Q4 | $699K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $275K | Buy |
|
|||||
|
2021
Q1 | $95K | Buy |
|
|||||
|
2020
Q4 | $102K | Sell |
|
|||||
|
2020
Q3 | $639K | Sell |
|
|||||
|
2020
Q2 | $1.04M | Buy |
|
|||||
|
2020
Q1 | $81K | Buy |
|
|||||
|
2019
Q4 | $13K | Sell |
|
|||||
|
2019
Q3 | $7K | Sell |
|
|||||
|
2019
Q2 | $61K | Buy |
|
|||||
|
2019
Q1 | $75K | Buy |
|
|||||
|
2018
Q4 | $21K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $29K | Buy |
|